Article Versions Notes

Freile JÁ, Ustyanovska Avtenyuk N, Corrales MG, Lourens HJ, Huls G, van Meerten T, Cendrowicz E, Bremer E. CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma. Biomedicines. 2022; 10(5):1175. https://doi.org/10.3390/biomedicines10051175

Freile, Jimena Álvarez, Natasha Ustyanovska Avtenyuk, Macarena González Corrales, Harm Jan Lourens, Gerwin Huls, Tom van Meerten, Ewa Cendrowicz, and Edwin Bremer. 2022. "CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma" Biomedicines 10, no. 5: 1175. https://doi.org/10.3390/biomedicines10051175

Freile, J. Á., Ustyanovska Avtenyuk, N., Corrales, M. G., Lourens, H. J., Huls, G., van Meerten, T., Cendrowicz, E., & Bremer, E. (2022). CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma. Biomedicines, 10(5), 1175. https://doi.org/10.3390/biomedicines10051175